From: Proceedings of the 23rd Paediatric Rheumatology European Society Congress: part one
Parameters | Controls (n = 51) | JIA MTX group (n = 20) | JIA BD group (n = 26) | p-value*†‡§ |
---|---|---|---|---|
Creatinine (mg/dl) | 0.42 ± 0.10 | 0.48 ± 0.08 | 0.54 ± 0.15 | <0.001†‡ |
Cystatin C (mg/l) | 0.66 ± 0.05 | 0.79 ± 0.06 | 0.77 ± 0.13 | <0.001†‡ |
BUN (mg/dl) | 11.72 ± 1.32 | 12.00 ± 2.59 | 13.61 ± 3.18 | 0.002‡ |
Microalbuminuria (mg/dl) | 1.09 ± 0.00 | 1.29 ± 0.60 | 1.54 ± 1.55 | 0.08 |
ESR (mm/h) | 1.00 ± 0.00 | 9.15 ± 6.64 | 15.00 ± 8.68 | <0.001†‡§ |
CRP (mg/dl) | 0.20 ± 0.00 | 0.34 ± 0.31 | 0.78 ± 084 | <0.001‡§ |
eGFR (ml/min/1.73 m2) | 121.9 ± 19.6 | 98.9 ± 8.3 | 98.1 ± 10.7 | <0.001†‡ |
RI | 0.60 ± 0.03 | 0.65 ± 0.02 | 0.68 ± 0.03 | <0.001†‡§ |
Duration of disease (years) | - | 3.96 ± 2.72 | 6.59 ± 3.18 | 0.35 |